Carol M. Moinpour, PhD

This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.

This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.

Quality of life (QOL) and health status data obtained from the Veterans Administration Cancer of the Prostate Outcomes Study (VA CaPOS) have the potential to add substantially to information available from other observational databases and